Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation

Craig I. Coleman, Jean-Baptiste Briere, Laurent Fauchier, Pierre Levy, Kevin Bowrin, Mondher Toumi, Aurélie Millier, Vanessa Taieb, Olivia Wu

Open source

DOI
10.1080/20016689.2019.1574541
Published
2019-01-01
Container
Journal of Market Access & Health Policy
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/20016689.2019.1574541,
  title = {Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation},
  author = {Craig I. Coleman and Jean-Baptiste Briere and Laurent Fauchier and Pierre Levy and Kevin Bowrin and Mondher Toumi and Aurélie Millier and Vanessa Taieb and Olivia Wu},
  year = {2019},
  journal = {Journal of Market Access \& Health Policy},
  doi = {10.1080/20016689.2019.1574541},
  url = {https://doi.org/10.1080/20016689.2019.1574541}
}

RIS

TY  - JOUR
TI  - Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
AU  - Craig I. Coleman
AU  - Jean-Baptiste Briere
AU  - Laurent Fauchier
AU  - Pierre Levy
AU  - Kevin Bowrin
AU  - Mondher Toumi
AU  - Aurélie Millier
AU  - Vanessa Taieb
AU  - Olivia Wu
PY  - 2019
JO  - Journal of Market Access & Health Policy
DO  - 10.1080/20016689.2019.1574541
UR  - https://doi.org/10.1080/20016689.2019.1574541
ER  - 

APA

Coleman, C. I., Briere, J., Fauchier, L., Levy, P., Bowrin, K., Toumi, M., Millier, A., Taieb, V., & Wu, O. (2019). Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation. Journal of Market Access & Health Policy. https://doi.org/10.1080/20016689.2019.1574541

Source records